Thus, we next measured expression of Pgc-1α and a GR target gene tyrosine aminotransferase (Tat) to analyze activation status of these regulatory pathways in response to the STZ-induced diabetes and the potential effect of insulin therapy. This evidence concerns the gene NR3C1 and diabetes mellitus.